• 北米< >
o 米国< />
o カナダ< />
• ヨーロッパ
o ドイツ
o フランス< />
o イギリス< />
o イタリア< />
o スペイン< />
• APAC
o 中国
o 日本< />
o インド< />
o オーストラリア< />
o 韓国< />
• ラテンアメリカ
o ブラジル< />
o メキシコ< />
o アルゼンチン< />
• 中東・アフリカ
o 南アフリカ
o サウジアラビア
o トルコ
• 北米< >
o 米国< />
o カナダ< />
• ヨーロッパ
o ドイツ
o フランス< />
o イギリス< />
o イタリア< />
o スペイン< />
• APAC
o 中国
o 日本< />
o インド< />
o オーストラリア< />
o 韓国< />
• ラテンアメリカ
o ブラジル< />
o メキシコ< />
o アルゼンチン< />
• 中東・アフリカ
o 南アフリカ
o サウジアラビア
o トルコ
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 4 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 5 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 6 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 7 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 8 North America Immunoglobulins Market by End-user 2020–2026 (%)
Table 9 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 10 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 11 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 12 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 13 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 14 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 15 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 16 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 17 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 18 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 19 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 20 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 21 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 22 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 23 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 24 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 25 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 26 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 27 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 28 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 29 Middle East & Africa Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 30 Middle East & Africa Immunoglobulins Market by Application 2020–2026 (%)
Table 31 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 32 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 (%)
Table 33 Takeda Pharmaceutical Company Limited: Major Product Offerings
Table 34 CSL: Major Product Offerings
Table 35 Grifols, S.A.: Major Product Offerings
Table 36 Kendrion: Major Product Offerings
Table 37 Octapharma: Major Product Offerings
Table 38 China Biologic Products Holdings, Inc.: Major Product Offerings
Table 39 Biotest AG: Major Product Offerings
Table 40 LFB S.A.: Major Product Offerings
Table 41 ADMA Biologics, Inc.: Major Product Offerings
Table 42 Omrix Biopharmaceuticals LTD: Major Product Offerings
Table 43 Zydus Cadila: Major Product Offerings
Table 44 Bharat Serums and Vaccines Limited: Major Product Offerings
Table 45 Reliance Life Sciences: Major Product Offerings
Table 46 Global Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 47 Global Immunoglobulins Market by Product Type 2020–2026 (%)
Table 48 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 49 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 50 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 51 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 52 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 53 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 54 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 55 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 56 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 57 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 58 Global Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 59 Global Immunoglobulins Market by Application 2020–2026 (%)
Table 60 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 61 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 62 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 63 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 64 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 65 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 66 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 67 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 68 Middle East & Africa Immunoglobulins Market by Application 2020−2026 ($ billion)
Table 69 Middle East & Africa Immunoglobulins Market by Application 2020−2026 (%)
Table 70 Global Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 71 Global Immunoglobulins Market by End-user 2020–2026 (%)
Table 72 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 73 North America Immunoglobulins Market by End-user 2020−2026 (%)
Table 74 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 75 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 76 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 77 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 78 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 79 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 80 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 81 Middle East & Africa Immunoglobulins Market by End-User 2020–2026 (%)
Table 82 Global Immunoglobulins Market by Geography 2020–2026 ($ billion)
Table 83 Global Immunoglobulins Market by Geography 2020–2026 (%)
Table 84 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Table 85 Global Intravenous Immunoglobulins Market 2020–2026 (%)
Table 86 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Table 87 Global Subcutaneous Immunoglobulins Market 2020–2026 (%)
Table 88 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Table 89 Global Intramuscular Immunoglobulins Market 2020–2026 (%)
Table 90 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 91 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 92 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Table 93 Global CIDP Immunoglobulins Market 2020–2026 (%)
Table 94 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 95 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 96 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Table 97 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 (%)
Table 98 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Table 99 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 (%)
Table 100 Global Immunoglobulins Market by Others 2020–2026 ($ billion)
Table 101 Global Immunoglobulins Market by Others 2020–2026 (%)
Table 102 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Table 103 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 (%)
Table 104 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Table 105 Global Homecare Immunoglobulins Market 2020–2026 (%)
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Immunoglobulins Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Developments in Plasma Fractionation Process
Exhibit 4 Impact of Immunoglobulins in Homecare
Exhibit 5 Impact of Recent Regulatory Approvals for Immunoglobulin
Exhibit 6 Impact of Use of IVIg During Transplant
Exhibit 7 Self-sufficiency Programs for Plasma-derived Medicinal Products
Exhibit 8 Impact of IVIg-associated Hemolysis
Exhibit 9 Impact of Shortage of Immunoglobulin Products
Exhibit 10 Global Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 11 Global Immunoglobulins Market by Product Type
Exhibit 12 Global Immunoglobulins Market by Application
Exhibit 13 Global Immunoglobulins Market by End-user
Exhibit 14 Global Immunoglobulins Market by Geography
Exhibit 15 Five Forces Analysis 2020
Exhibit 16 Incremental Growth by Product Type 2020 & 2026
Exhibit 17 Global Immunoglobulins Market by Product Type
Exhibit 18 Global Immunoglobulins Market by Product Type: Incremental Growth 2020–2026 ($ billion)
Exhibit 19 Global Immunoglobulins Market by Product Type: Absolute Growth 2020–2026 (%)
Exhibit 20 Global Intravenous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 21 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 22 Incremental Growth by Geography 2020 & 2026
Exhibit 23 Global Subcutaneous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 24 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 25 Incremental Growth by Geography 2020 & 2026
Exhibit 26 Global Intramuscular Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 27 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 28 Incremental Growth by Geography 2020 & 2026
Exhibit 29 Incremental Growth by Segment 2020 & 2026
Exhibit 30 Global Immunoglobulins Market by Application
Exhibit 31 Global Immunoglobulins Market by Application: Incremental Growth 2020–2026 ($ billion)
Exhibit 32 Global Immunoglobulins Market by Application: Absolute Growth 2020–2026 ($ billion)
Exhibit 33 Global Primary Immunodeficiency Market: Incremental & Absolute Growth
Exhibit 34 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 35 Incremental Growth by Geography 2020 & 2026
Exhibit 36 Global CIDP Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 37 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 38 Incremental Growth by Geography 2020 & 2026
Exhibit 39 Global Secondary Immunodeficiency Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 40 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 41 Incremental Growth by Geography 2020 & 2026
Exhibit 42 Global Immune Thrombocytopenic Purpura Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 43 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 44 Incremental Growth by Geography 2020 & 2026
Exhibit 45 Global Myasthenia Gravis Immunoglobulins Market: Incremental Growth & Absolute Growth
Exhibit 46 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Geography 2020 & 2026
Exhibit 48 Global Immunoglobulins Market by Others: Incremental & Absolute Growth
Exhibit 49 Global Other Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 50 Incremental Growth by Geography 2020 & 2026
Exhibit 51 Incremental Growth by Application 2020 & 2026
Exhibit 52 Global Immunoglobulins Market by End-user
Exhibit 53 Global Immunoglobulins Market by End-user: Incremental Growth 2020–2026 ($ billion)
Exhibit 54 Global Immunoglobulins Market by End-user: Absolute Growth 2020–2026 (%)
Exhibit 55 Global Hospitals & Clinics Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 56 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 57 Incremental Growth by Geography 2020 & 2026
Exhibit 58 Global Homecare Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 59 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Incremental Growth by Geography 2020 & 2026
Exhibit 62 Global Immunoglobulins Market: Key Countries
Exhibit 63 Global Immunoglobulins Market by Geography: Incremental Growth 2020–2026 ($ billion)
Exhibit 64 Global Immunoglobulins Market by Geography: Absolute Growth 2020–2026 (%)
Exhibit 65 North America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 66 North America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 67 Incremental Growth by Product Type 2020 & 2026
Exhibit 68 Incremental Growth by Application 2020 & 2026
Exhibit 69 Incremental Growth by End-user 2020 & 2026
Exhibit 70 Incremental Growth in North America 2020 & 2026
Exhibit 71 Immunoglobulins Market in US 2020–2026 ($ billion)
Exhibit 72 Immunoglobulins Market in Canada 2020–2026 ($ billion)
Exhibit 73 Europe Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 74 Europe Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 75 Incremental Growth by Product Type 2020 & 2026
Exhibit 76 Incremental Growth by Application 2020 & 2026
Exhibit 77 Incremental Growth by End-user 2020 & 2026
Exhibit 78 Incremental Growth in Europe 2020 & 2026
Exhibit 79 Immunoglobulins Market in Germany 2020–2026 ($ billion)
Exhibit 80 Immunoglobulins Market in France 2020–2026 ($ billion)
Exhibit 81 Immunoglobulins Market in UK 2020–2026 ($ billion)
Exhibit 82 Immunoglobulins Market in Italy 2020–2026 ($ billion)
Exhibit 83 Immunoglobulins Market in Spain 2020–2026 ($ billion)
Exhibit 84 APAC Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 85 Immunoglobulins Market in APAC 2020–2026 ($ billion)
Exhibit 86 Incremental Growth by Product Type 2020 & 2026
Exhibit 87 Incremental Growth by Application 2020 & 2026
Exhibit 88 Incremental Growth by End-user 2020 & 2026
Exhibit 89 Incremental Growth in APAC 2020 & 2026
Exhibit 90 Immunoglobulins Market in China 2020–2026 ($ billion)
Exhibit 91 Immunoglobulins Market in Japan 2020–2026 ($ billion)
Exhibit 92 Immunoglobulins Market in India 2020–2026 ($ billion)
Exhibit 93 Immunoglobulins Market in Australia 2020–2026 ($ billion)
Exhibit 94 Immunoglobulins Market in South Korea 2020–2026 ($ billion)
Exhibit 95 Latin America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 96 Latin America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 97 Incremental Growth by Product Type 2020 & 2026
Exhibit 98 Incremental Growth by Application 2020 & 2026
Exhibit 99 Incremental Growth by End-user 2020 & 2026
Exhibit 100 Incremental Growth in Latin America 2020 & 2026
Exhibit 101 Immunoglobulins Market in Brazil 2020–2026 ($ billion)
Exhibit 102 Immunoglobulins Market in Mexico 2020–2026 ($ billion)
Exhibit 103 Immunoglobulins Market in Argentina 2020–2026 ($ billion)
Exhibit 104 Middle East & Africa Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 105 Middle East & Africa Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 106 Incremental Growth by Product Type 2020 & 2026
Exhibit 107 Incremental Growth by Application 2020 & 2026
Exhibit 108 Incremental Growth by End-user 2020 & 2026
Exhibit 109 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 110 Immunoglobulins Market in South Africa 2020–2026 ($ billion)
Exhibit 111 Immunoglobulins Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 112 Immunoglobulins Market in Turkey 2020–2026 ($ billion)
Exhibit 113 Global Immunoglobulins Market: Vendor Market Share (2020)
Exhibit 114 Takeda Pharmaceutical Company Limited: Total Revenue 2018−2020 ($ billion)
Exhibit 115 Takeda Pharmaceutical Company Limited: Total Revenue by Geography 2019 & 2020 ($ billion)
Exhibit 116 Takeda Pharmaceutical Company Limited: R&D Expenditure 2018−2020 ($ billion)
Exhibit 117 Takeda Pharmaceutical Company Limited: Total Revenue by Immunoglobin 2018−2020 ($ billion)
Exhibit 118 CSL Limited: Total Revenue 2018−2020 ($ million)
Exhibit 119 CSL Limited: R&D Expenditure 2018−2020 ($ million)
Exhibit 120 Grifols, S.A.: Total Revenue 2018−2020 ($ million)
Exhibit 121 Grifols, S.A.: R&D Expenditure 2018−2020 ($ million)
Exhibit 122 Kendrion: Total Revenue 2018−2020 ($ million)
Exhibit 123 Kendrion: R&D Expenditure 2018−2020 ($ million)
Exhibit 124 Octapharma AG: Total Revenue 2018−2020 ($ million)
Exhibit 125 Octapharma AG: R&D Expenditure 2018−2020 ($ million)